Samik Pharmaceutical Co. Ltd.
🇰🇷South Korea
A Clinical Trial to Evaluate the Pharmacokinetics and Safety of SIPS-2209-1 in Healthy Korean Volunteers
- First Posted Date
- 2023-03-28
- Last Posted Date
- 2023-04-18
- Lead Sponsor
- Samik Pharmaceutical Co. Ltd.
- Target Recruit Count
- 40
- Registration Number
- NCT05787873
- Locations
- 🇰🇷
Samik Pharmaceutical Co. Ltd., Incheon, Korea, Republic of
© Copyright 2025. All Rights Reserved by MedPath